Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
- Ampudia-Blasco, F.J.
- Romera, I.
- Ariño, B.
- Gomis, R.
Aldizkaria:
International Journal of General Medicine
ISSN: 1178-7074
Argitalpen urtea: 2017
Alea: 10
Orrialdeak: 23-26
Mota: Artikulua
